Idenix Pharmaceuticals v. Gilead Sciences
Already the largest patent iN- fringement verdict in U.S. history, the $2.5 billion in damages awarded to Merck & Co. Inc.’s Idenix unit could grow by as much as three times the amount assessed by a federal jury in Wilmington, Delaware, on Dec. 15. Stephanie Parker of Jones Day led Idenix’s legal team, joined by her partners Anthony Insogna, Calvin Griffith, Jennifer Swize and others at the firm. John Day, a director of Ashby & Geddes’ intellectual property group, also represented Idenix, along with the firm’s IP group chair Steven Balick and IP director Andrew Mayo.
